Clinical and therapeutic outcomes of pediatric pituitary adenomas: a single pituitary center experience

Fatih Kilci1, Jeremy Huw Jones2, Melih Çaklılı3

  • 1Department of Pediatric Endocrinology, School of Medicine, Kocaeli University, Kocaeli, Turkey.

Endocrine
|October 1, 2023
PubMed

Insights

Pediatric pituitary adenomas (PPAs) are rare but challenging. This study found non-functioning adenomas were most common, and hormonal issues often resolved with treatment, with low rates of new deficiencies post-surgery.

Area of Science:

  • Pediatric Endocrinology
  • Neuro-oncology
  • Pituitary Medicine

Background:

  • Pediatric pituitary adenomas (PPAs) are rare tumors, often benign but complex to manage.
  • Existing research on PPAs predominantly stems from surgical case series.
  • A comprehensive understanding of PPA clinical features and outcomes in a multidisciplinary setting is needed.

Purpose of the Study:

  • To characterize the clinical presentation, hormonal status, and treatment outcomes of pediatric patients with pituitary adenomas.
  • To evaluate the effectiveness of combined neuroendocrine and surgical management for pediatric pituitary adenomas.
  • To compare findings with existing literature and identify factors influencing outcomes.

Main Methods:

  • Retrospective review of demographic, clinical, and endocrinological data for patients under 19 diagnosed with PPA between 2002-2022 at a single center.
  • Systematic review of 21 relevant studies published in the past two decades.
  • Analysis of adenoma subtypes, presenting symptoms, hormonal deficiencies, and surgical outcomes.

Main Results:

  • The cohort included 79 patients (median age 15.8 years); non-functioning adenomas (NFAs) were most frequent (35.5%), followed by prolactinomas (29.1%).
  • Common symptoms included headache, visual impairment, and menstrual irregularities; central hypothyroidism was the most frequent hormonal deficiency (31.6%).
  • Endoscopic endonasal transsphenoidal surgery (EETS) was performed in 63.2% of patients, with 62% experiencing recovery of endocrine function and low rates of new deficiencies (4% hypopituitarism).

Conclusions:

  • This study presents one of the largest pediatric pituitary adenoma series, highlighting a higher prevalence of NFAs than previously reported.
  • Appropriate endocrinological and surgical management largely resolved hormonal disorders at diagnosis, with a low incidence of post-EETS pituitary hormonal deficiencies.
  • Management at high-volume pituitary centers is recommended for pediatric patients with PPA to ensure long-term outcomes and minimize morbidity.
Abstract